Dianthus Therapeutics Balance Sheet (2017-2025) | DNTH

Balance Sheet Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
49.29M155.03M157.54M131.65M71.77M54.83M36.88M15.37M23.21M40.28M157.28M132.32M329.72M314.17M33.67M21.95M10.12M11.95M55.98M50.25M
Short-term Investments (Quarter)
83.00M52.77M35.08M45.28M84.84M84.59M69.26M60.12M1.78M14.96M32.59M41.39M47.31M46.54M247.45M252.45M253.11M244.15M346.63M353.21M
Cash & Current Investments (Quarter)
132.29M207.81M192.62M176.93M156.60M139.43M106.14M75.49M24.99M55.24M189.87M173.72M377.04M360.71M281.12M274.39M263.23M256.10M402.61M403.45M
Receivables (Quarter)
5.60M0.75M0.49M0.80M1.60M2.70M0.20M1.30M0.04M5.10M0.10M
Prepaid Assets (Quarter)
2.81M2.38M3.86M3.77M3.63M2.62M3.81M0.03M2.91M1.04M0.02M3.25M0.47M3.31M0.05M0.35M0.39M0.11M6.21M5.09M
Current Assets (Quarter)
135.10M210.19M196.47M180.69M160.24M142.04M132.10M82.03M83.44M78.64M191.45M177.45M380.93M365.69M287.49M280.90M271.00M263.61M413.82M409.44M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
7.74M8.41M7.98M7.46M6.98M6.63M6.32M0.14M0.20M0.18M0.20M0.19M0.19M0.19M0.19M0.21M0.18M0.30M
Long-Term Investments (Quarter)
61.48M81.73M68.31M51.70M152.87M110.14M
Long-Term Deferred Tax (Quarter)
21.70M
Other Non-Current Assets (Quarter)
1.78M1.78M1.78M1.78M1.78M1.78M0.06M0.06M0.06M0.12M0.07M1.15M0.07M0.07M0.23M9.63M0.23M9.18M0.17M9.72M
Non-Current Assets (Quarter)
9.52M10.19M9.76M9.24M34.15M33.08M32.03M1.08M1.01M1.95M1.54M3.27M66.76M93.10M77.58M62.47M163.62M121.48M
Assets (Quarter)
144.62M220.38M206.24M189.93M194.38M175.12M164.12M83.11M83.44M78.64M192.46M179.41M382.46M368.96M354.25M374.01M348.58M326.08M577.45M530.92M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.11M2.93M1.89M3.04M4.44M2.05M2.58M1.17M1.08M0.81M1.37M2.61M2.61M3.69M7.57M4.58M8.27M5.40M6.71M9.72M
Payables (Quarter)
2.11M2.93M1.89M3.04M4.44M2.05M2.58M1.17M1.08M0.81M1.37M2.61M2.61M3.69M7.57M4.58M8.27M5.40M6.71M9.72M
Accumulated Expenses (Quarter)
7.09M8.15M8.26M7.82M6.41M5.79M6.72M6.61M1.57M3.22M11.20M6.50M5.85M5.86M7.73M13.07M7.98M14.00M15.98M19.45M
Other Accumulated Expenses (Quarter)
0.36M0.22M0.28M
Current Leases (Quarter)
3.25M3.42M3.62M0.35M0.41M0.42M0.40M0.38M0.31M0.32M0.23M0.21M0.22M0.37M
Current Deferred Revenue (Quarter)
0.10M0.10M0.10M0.10M0.10M0.48M0.48M0.48M0.95M1.19M
Total Current Liabilities (Quarter)
9.21M11.08M10.15M10.86M14.09M11.26M12.92M8.22M5.98M4.03M13.08M9.63M8.96M10.03M15.71M18.45M16.95M20.09M23.86M30.73M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
6.36M6.40M6.40M6.40M0.79M0.74M0.74M0.72M0.68M0.64M1.91M1.85M1.78M6.07M5.77M
Preferred Stock Liabilities (Quarter)
118.02M
Operating Leases (Quarter)
32.35M31.61M27.18M0.44M0.26M0.17M0.10M0.03M1.17M1.17M1.12M1.07M1.02M
Total Non-Current Liabilities (Quarter)
Total Liabilities (Quarter)
15.56M17.49M16.55M17.26M43.20M39.44M40.10M9.45M5.98M4.03M14.08M10.54M9.78M10.74M16.35M21.53M19.97M23.00M30.99M37.52M
Shareholder's Equity
Common Equity (Quarter)
129.06M202.89M189.69M-17.25M-22.07M-27.48M-34.75M-44.37M-50.82M-61.46M178.38M168.87M372.69M358.22M337.90M352.48M328.61M303.08M546.45M493.40M
Shareholder's Equity (Quarter)
129.06M202.89M189.69M-17.25M-22.07M-27.48M-34.75M-44.37M-50.82M-61.46M178.38M168.87M372.69M358.22M337.90M352.48M328.61M303.08M546.45M493.40M
Liabilities and Shareholders Equity (Quarter)
144.62M220.38M206.24M189.93M194.38M175.12M164.12M83.11M83.44M78.64M192.46M179.41M382.46M368.96M354.25M374.01M348.58M326.08M577.45M530.92M
Retained Earnings (Quarter)
0.01M-288.85M-306.27M-0.03M-0.47M-365.79M-78.90M-45.87M-431.20M-434.50M-78.90M0.05M-103.17M-120.80M-146.00M-174.39M-203.90M-235.53M-272.30M-336.73M
Treasury Shares (Quarter)
0.29M0.02M
Shares Outstanding (Quarter)
48.60M58.51M58.78M0.88M10.33M33.34M0.88M0.88M33.34M33.34M14.82M29.35M29.35M29.37M31.12M32.13M32.18M42.85M43.22M